Comparison of Intubation Duration Between Rapid Sequence Intubation (RSI) Technique and Non-RSI Technique

June 1, 2016 updated by: Mingkwan Wongyingsinn, MD, Siriraj Hospital

Comparison of Intubation Duration Between Rapid Sequence Intubation Technique and Non- Rapid Sequence Intubation Technique in Siriraj Hospital by Emergency Medicine Residences

The purpose of this study is to evaluate intubation duration between rapid sequence intubation technique (RSI) and non-rapid sequence intubation technique (non-RSI) performed by emergency medicine residents in Siriraj hospital.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

A prospective cohort study was conducted in the non-traumatic emergency department (ED).

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bangkok, Thailand, 10700
        • Siriraj Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients required airway control by tracheal intubation

Exclusion Criteria:

  • cardiac arrest

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RSI technique

Intubation with RSI technique. RSI technique includes the administration of inductive and neuromuscular blocking agents to facilitate an intubation.

In this study, we have no restriction of medication use. Physicians can chose any of medication as an individual judgement.

All medications are administered only one dose before intubation

Anesthetics:

Propofol 2-2.5 mg/kg Thiopental 3-5mg/kg Etomidate 1-2mg/kg

Neuromuscular blocking agents:

Succinylcholine 1-1.5mg/kg Rocuronium 0.9mg/kg

Opioid:

Fentanyl 1-2ug/kg

Other Names:
  • Rapid Sequence Intubation
No Intervention: Non-RSI
Intubation without RSI technique. No any medication use during intubation period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The overall intubation duration
Time Frame: Participants will be followed for the overall intubation duration until confirmation the endotracheal position, an expected average of 2 minutes
The overall intubation duration is recorded on the decision to intubation patient and corresponds to the time of confirmation the endotracheal position by chest auscultation
Participants will be followed for the overall intubation duration until confirmation the endotracheal position, an expected average of 2 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the intubation duration
Time Frame: Participants will be followed for the intubation duration until confirmation the endotracheal position, an expected average of 5 minutes
The intubation duration (Ti), it is defined from application the laryngoscope into the patient's mouth to the time of confirmation an endotracheal position
Participants will be followed for the intubation duration until confirmation the endotracheal position, an expected average of 5 minutes
Complication
Time Frame: Participants will be followed in the period of staying in the emergency room and hospital, an expected average of 4 weeks
Complications occur during and after intubation peroid are recorded and monitored until patients are discharged fromt the hospital.
Participants will be followed in the period of staying in the emergency room and hospital, an expected average of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mingkwan Wongyingsinn, M.D., Siriraj Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

November 9, 2011

First Submitted That Met QC Criteria

November 17, 2011

First Posted (Estimate)

November 18, 2011

Study Record Updates

Last Update Posted (Estimate)

June 2, 2016

Last Update Submitted That Met QC Criteria

June 1, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • SIRB213

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tracheal Intubation Morbidity

Clinical Trials on RSI

Subscribe